No, BPC-157 is not FDA approved
(PubMed) Singh SV, Powolny AA, Stan SD, et al
Aussie Peptides supplies BPC-157 domestically for legitimate research purposes only, and purchasers are responsible for ensuring their intended use complies with all applicable laws and regulations
Diabetes should be well-managed before starting therapy Active pituitary tumors: Stimulating a gland with an active tumor is contraindicated Monitoring Requirements Safe use of CJC-1295/Ipamorelin requires ongoing physician monitoring: Baseline labs: IGF-1, fasting glucose, HbA1c, thorough metabolic panel, CBC 4-6 week follow-up: IGF-1 to confirm dose response
Light food settles the stomach
EC 50 values were calculated via a non-linear regression analysis via GraphPad software